| Identification | Back Directory | [Name]
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide | [CAS]
521284-19-5 | [Synonyms]
Mirabegron INT 1
Lactose Impurity 13
2-hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide
(R)-N-(4-nitrophenethyl)-2-hydroxy-2-phenylacetamide
(R)-2-Hydroxy-N-(4-nitrophenethyl)-2-phenylacetamide
Mirabegron Impurity 8 (Mirabegron stage -I Impurity )
R-a-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide
(R) -N- (4-Nitrophenylethyl) -2-hydroxy-2-phenylacetamide
(2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide
R-alpha-hydroxy-N-[2-(4-nitrophenyl)ethyl]- BenzeneacetaMide
BenzeneacetaMide, -hydroxy-N-[2-(4-nitrophenyl)ethyl]-, (R)-
BenzeneacetaMide, a-hydroxy-N-[2-(4-nitrophenyl)ethyl]-, (aR)-
R-2-((4-aminophenethyl)amino)-1-phenylethan-1-ol hydrochloride
(ALPHAR)-ALPHA-hydroxy-N-[2-(4-nitrophenyl)ethyl]phenylacetamide
(R) Alpha hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide
(alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide
(R) -2- hydroxy -N- [2- (4- nitrophenyl) ethyl] -2-phenylacetamide
(Alphar) -α-hydroxy-N - [2- (4-nitrophenyl) ethyl] phenylacetamide
High purity CAS 521284-19-5 (alphaR)-alpha-Hydroxy-N-[2-(4-nitrophenyl)ethyl]benzeneacetamide in stock | [EINECS(EC#)]
300-560-8 | [Molecular Formula]
C16H16N2O4 | [MDL Number]
MFCD22200231 | [MOL File]
521284-19-5.mol | [Molecular Weight]
300.31 |
| Chemical Properties | Back Directory | [Melting point ]
116-119°C | [Boiling point ]
584.8±50.0 °C(Predicted) | [density ]
1.294 | [storage temp. ]
Sealed in dry,Room Temperature | [solubility ]
DMSO (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
12.50±0.20(Predicted) | [color ]
Off-White to Pale Yellow | [Optical Rotation]
-29.3°(C=0.01g/ml ETOH) | [Major Application]
pharmaceutical | [InChI]
InChI=1/C16H16N2O4/c19-15(13-4-2-1-3-5-13)16(20)17-11-10-12-6-8-14(9-7-12)18(21)22/h1-9,15,19H,10-11H2,(H,17,20)/t15-/s3 | [InChIKey]
YWGDTDSOHPHFAQ-UJHUVDBMNA-N | [SMILES]
C1([C@@H](O)C(NCCC2=CC=C([N+]([O-])=O)C=C2)=O)=CC=CC=C1 |&1:1,r| |
| Hazard Information | Back Directory | [Uses]
(2R)-2-Hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide is an intermediate used to prepare (aminothiazolyl)acetanilide derivatives via coupling reactions for treatment of diabetes. | [Uses]
(ALPHAR)-ALPHA-hydroxy-N-[2-(4-nitrophenyl)ethyl]phenylacetamide is an organic amide, which can be used as a pharmaceutical intermediate. | [Synthesis]
GENERAL STEPS: To a stirred solution of (R)-mandelic acid (97.61 g) in acetonitrile (1000 mL) was slowly added trimethyl borate (66.66 g) at 28 °C (±2 °C). After addition, the reaction system was warmed to 58 °C (±2 °C) and maintained for 90 min. Maintaining this temperature, 4-nitrophenylethylamine hydrochloride (100.0 g) was added to the reaction solution. Subsequently, N,N-diisopropylethylamine (82.92 g) was added slowly and the reaction mixture was heated to reflux for 12 hours. After completion of the reaction, the system was cooled to 30 °C (±2 °C) and diluted with ethyl acetate (1100 mL) and 1 M aqueous hydrochloric acid (1400 mL). The organic phase was separated and washed with 1M aqueous hydrochloric acid solution, 5% aqueous sodium hydroxide solution and saturated saline in turn. The organic phase was concentrated under reduced pressure and the residue was recrystallized from toluene (500 mL). The resulting solid was washed with toluene and dried under vacuum at 48 °C (±2 °C) to give the light yellow crystalline product (R)-2-hydroxy-N-[2-(4-nitrophenyl)ethyl]-2-phenylacetamide. Yield: 125 g (84.3%); HPLC purity: 98.65%. | [References]
[1] Advanced Synthesis and Catalysis, 2017, vol. 359, # 20, p. 3665 - 3673
[2] Patent: WO2015/44965, 2015, A1. Location in patent: Page/Page column 32
[3] Patent: CN105481705, 2016, A. Location in patent: Paragraph 0017; 0018; 0019
[4] Patent: EP1440969, 2004, A1. Location in patent: Page 5-6
[5] Patent: EP1559427, 2005, A1. Location in patent: Page/Page column 5-6 |
|
|